Innovation and Global Reach Are at the Heart of Worldwide’s Approach to Melanoma Studies
Melanoma is a form of skin cancer associated with exposure to UV radiation. In recent years, researchers have been successful in developing safer and more effective treatments that render more sustainable results, and many of the advances in melanoma studies are now being applied to research of other forms of cancer. Current investigations focus on preventative therapies, early detection, and dormancy/relapse. Because the landscape of oncology research is growing in complexity, clinical studies require precision and strategic innovation in protocol design and execution, as well as in patient recruitment and monitoring.
With its combined expertise in IMID and oncology and a long history navigating the evolving intricacies of the clinical trial landscape, Worldwide Clinical Trials is the full-service CRO your melanoma study needs. We have a presence in 60+ countries, access to global patient populations, and an invaluable understanding of regional variations in standards of care and regulatory considerations. With access to state-of-the-art digital technology, we can use predictive analytics to optimize enrollment from the outset and ensure patient compliance throughout the trial.